Seth Degroot

Our mission is to accelerate the discovery of new medicines with physiologically-relevant, structured human cells that improve cell-based assay outcomes. We develop and scalably manufacture human induced pluripotent stem (iPS) cell-derived cardiac and neural platforms for drug discovery and development. Predictive, accurate, and consistent, our human models enable scientists to quickly and economically conduct research with improved outcomes in a simplified workflow. We also collaborate with drug discovery organizations to test their compounds with our in-house screening capabilities, create new cell-based models, and operationalize their human iPS cells at large scale for high throughput screening. StemoniX microHeart® products in high density plate formats provide researchers with structurally aligned cardiac cells resembling native human heart tissue with accelerated features of cell maturity. StemoniX microBrain® products in high density formats are physiologically relevant with biology, activity, functional maturity that mimic native human brain tissue. Available pre-plated to simplify your workflow, microHeart and microBrain are delivered in ambient conditions and ready for assay use soon after delivery. With leading-edge iPSC technologies, we are helping global institutions bring the most promising medicines to patients. Contact us at info@stemonix.com to discuss how StemoniX products and services can accelerate your discoveries.

VRChat, Inc. is one of the leading Virtual World platforms, hosting one of the largest active online communities of users and creators. We have secured key investment from major partners, allowing us to grow and develop VRChat for the foreseeable future. Dive into VRChat on our website at VRChat.com or our Twitter at https://twitter.com/VRChat.

Gravity Fund is a thesis driven, early-stage Venture Capital firm investing in extraordinary entrepreneurs building bleeding-edge technology on the brink of commercialization in four defined sectors: Consumer Marketplaces & Applications, Fintech & Crypto, Enterprise Software, and Life Sciences. We utilize our deep domain expertise to uniquely understand and creatively solve for the problems of the ambitious founders we invest in.

Our mission is to accelerate the discovery of new medicines with physiologically-relevant, structured human cells that improve cell-based assay outcomes. We develop and scalably manufacture human induced pluripotent stem (iPS) cell-derived cardiac and neural platforms for drug discovery and development. Predictive, accurate, and consistent, our human models enable scientists to quickly and economically conduct research with improved outcomes in a simplified workflow. We also collaborate with drug discovery organizations to test their compounds with our in-house screening capabilities, create new cell-based models, and operationalize their human iPS cells at large scale for high throughput screening. StemoniX microHeart® products in high density plate formats provide researchers with structurally aligned cardiac cells resembling native human heart tissue with accelerated features of cell maturity. StemoniX microBrain® products in high density formats are physiologically relevant with biology, activity, functional maturity that mimic native human brain tissue. Available pre-plated to simplify your workflow, microHeart and microBrain are delivered in ambient conditions and ready for assay use soon after delivery. With leading-edge iPSC technologies, we are helping global institutions bring the most promising medicines to patients. Contact us at info@stemonix.com to discuss how StemoniX products and services can accelerate your discoveries.

VRChat, Inc. is one of the leading Virtual World platforms, hosting one of the largest active online communities of users and creators. We have secured key investment from major partners, allowing us to grow and develop VRChat for the foreseeable future. Dive into VRChat on our website at VRChat.com or our Twitter at https://twitter.com/VRChat.

Brightstone Venture Capital is an early-stage, growth-oriented venture capital management firm based in Minneapolis. Since 1985, Brightstone has managed multiple venture partnerships and has made over 100 equity investments into successful companies such as: Wasabi Tech, FLYR Labs, Mosaic, VRChat, Definity Health, HomeSpotter, FlipGrid, GRAVIE, AppTec Labs, CRYOsa, Celcuity, CREXi, CADRE, VersusGame, and a variety of technology and life-science companies nationwide.

Simple Science technology is based on the remarkable properties of Hypochlorous Acid. Hypochlorous is produced naturally by our own white blood cells as part of the body’s immune system to fight pathogens and infections. Simple Science technology replicates nature’s chemistry and creates unique, safe, and highly effective antimicrobial solutions with shelf stable hypochlorous products for the consumer and professional care markets.  Visit our website to explore the skin care and disinfecting products under the SkinSmart Antimicrobial or CleanSmart brands that we offer. Simple Science also partners with leading global brands to deliver hypochlorous innovation to products from ophthalmology to infant care.